Original Article
Oncogene (2006) 25, 176–185. doi:10.1038/sj.onc.1209049; published online 19 September 2005
Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras–MAPK signaling in human cancer cells
H Ota1,2, E Tokunaga1,3, K Chang1, M Hikasa1, K Iijima2, M Eto2, K Kozaki2, M Akishita2, Y Ouchi2 and M Kaneki1,3
- 1Department of Anesthesia & Critical Care, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
- 2Department of Geriatric Medicine, Graduate School of Medicine, University of Tokyo, Bunkyo, Tokyo, Japan
- 3Shriners Hospital for Children, Boston, MA, USA
Correspondence: Dr M Kaneki, Department of Anesthesia & Critical Care, Massachusetts General Hospital, Harvard Medical School, 149 Thirteenth Street, Rm 6604, Charlestown, MA 02129, USA. E-mail: mkaneki@partners.org
Received 23 June 2005; Accepted 8 July 2005; Published online 19 September 2005.
Abstract
The induction of senescence-like growth arrest has emerged as a putative contributor to the anticancer effects of chemotherapeutic agents. Clinical trials are underway to evaluate the efficacy of inhibitors for class I and II histone deacetylases to treat malignancies. However, a potential antiproliferative effect of inhibitor for Sirt1, which is an NAD+-dependent deacetylase and belongs to class III histone deacetylases, has not yet been explored. Here, we show that Sirt1 inhibitor, Sirtinol, induced senescence-like growth arrest characterized by induction of senescence-associated
-galactosidase activity and increased expression of plasminogen activator inhibitor 1 in human breast cancer MCF-7 cells and lung cancer H1299 cells. Sirtinol-induced senescence-like growth arrest was accompanied by impaired activation of mitogen-activated protein kinase (MAPK) pathways, namely, extracellular-regulated protein kinase, c-jun N-terminal kinase and p38 MAPK, in response to epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I). Active Ras was reduced in Sirtinol-treated senescent cells compared with untreated cells. However, tyrosine phosphorylation of the receptors for EGF and IGF-I and Akt/PKB activation were unaltered by Sirtinol treatment. These results suggest that inhibitors for Sirt1 may have anticancer potential, and that impaired activation of Ras–MAPK pathway might take part in a senescence-like growth arrest program induced by Sirtinol.
Keywords:
Sirt1, Sirtinol, cellular senescence, Ras, MAPK, Akt/PKB
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Nature Genetics Article (01 Sep 1999)
Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B
Oncogene Original Article
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect
Oncogene Original Article
SIRT1 negatively regulates HDAC1-dependent transcriptional repression by the RBP1 family of proteins
Oncogene Original Article
